Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: A systematic review and meta-analysis

Published:2013-10 Issue:4 Volume:168 Page:4234-4243
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Yang Jie,Chen Yanming,Li Xiaoqi,Wei Xiaowen,Chen Xi,Zhang Lanning,Zhang Yuxiao,Xu Qiang,Wang Hongjuan,Li Yang,Lu Caiyi,Chen Wei,Zeng Changqing,Yin Tong

Funder

National Natural Science Foundation of China

Clinical Research Supportive Fund, General Hospital of Chinese People's Liberation Army

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference79 articles.

1. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing;Johnson;Clin Pharmacol Ther,2011

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

4. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

5. A new era for anticoagulation in atrial fibrillation;Mega;N Engl J Med,2011

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Influence of Genetic Polymorphisms on Warfarin Dosage Requirements in Cardiac Valve Surgery Patients;Cukurova Anestezi ve Cerrahi Bilimler Dergisi;2024-06-30

2. Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case‐cohort;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-04-30

3. COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment;Journal of Thrombosis and Thrombolysis;2024-03-25

4. Association between CYP2C9 and VKORC1 genetic polymorphisms and efficacy and safety of warfarin in Chinese patients;Pharmacogenetics and Genomics;2024-03-07

5. Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?;The Pharmacogenomics Journal;2024-03-05